Treatment of Tuberculosis ? Adjuvant Therapies to Increase the Efficiency of Antibiotic TreatmentsThere is growing evidence that resistance to Mycobacterium tuberculosis infection is governed in large part by the regulation of host cell death. Lipid mediators called eicosanoids are thought to play a central role in this process. The subject invention is a novel method of enhancing the efficacy of antibiotic treatments for Mycobacterium tuberculosis infection by co-administering an inhibitor of 5-lipoxygenase and a COX-2 dependent prostaglandin. Inhibition of 5-lipoxygenase and treatment with prostaglandin E2 results in alteration of the eicosanoid balance. The synergistic effects of altering the eicosanoid balance and treatment with antibiotics is believed to result in more efficient reduction of the bacterial burden and thus, the period of antibiotic administration and antibiotic dosage could potentially be reduced. In vivo data from mouse models can be provided upon request.
Source:
Treatment of Tuberculosis ? Adjuvant Therapies to Increase the Efficiency of Antibiotic TreatmentsLinkback:
https://tubagbohol.mikeligalig.com/index.php?topic=65289.0